Related references
Note: Only part of the references are listed.Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia
Angaja Phalguni et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2023)
Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force
Kamilla W. Miskowiak et al.
BIPOLAR DISORDERS (2022)
Can rodent models elucidate the pathomechanisms of genetic epilepsy?
Motohiro Okada
BRITISH JOURNAL OF PHARMACOLOGY (2022)
High frequency oscillations play important roles in development of epileptogenesis/ictogenesis via activation of astroglial signallings
Kouji Fukuyama et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Impact of 5-HT7 receptor inverse agonism of lurasidone on monoaminergic tripartite synaptic transmission and pathophysiology of lower risk of weight gain
Kouji Fukuyama et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Brivaracetam and Levetiracetam Suppress Astroglial L-Glutamate Release through Hemichannel via Inhibition of Synaptic Vesicle Protein
Kouji Fukuyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Hypothalamic AMPK as a possible target for energy balance-related diseases
Miguel Lopez
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
Brexpiprazole Reduces 5-HT7 Receptor Function on Astroglial Transmission Systems
Kouji Fukuyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Dose-Dependent Biphasic Action of Quetiapine on AMPK Signalling via 5-HT7 Receptor: Exploring Pathophysiology of Clinical and Adverse Effects of Quetiapine
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Thalamocortical contributions to cognitive task activity
Kai Hwang et al.
ELIFE (2022)
Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases
Alejandro Quintero-Villegas et al.
MOLECULAR MEDICINE (2022)
Autophagy and apoptosis cascade: which is more prominent in neuronal death?
Rohan Gupta et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A network meta-analysis of the dose-response effects of lurasidone on acute schizophrenia
Manit Srisurapanont et al.
SCIENTIFIC REPORTS (2021)
Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
Ruri Okubo et al.
FRONTIERS IN PSYCHIATRY (2021)
Neuropsychological evidence of multi-domain network hubs in the human thalamus
Kai Hwang et al.
ELIFE (2021)
Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions
Kouji Fukuyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Effects of an Atypical Antipsychotic, Zotepine, on Astroglial L-Glutamate Release through Hemichannels: Exploring the Mechanism of Mood-Stabilising Antipsychotic Actions and Antipsychotic-Induced Convulsion
Kouji Fukuyama et al.
PHARMACEUTICALS (2021)
Cognitive impairment after focal brain lesions is better predicted by damage to structural than functional network hubs
Justin Reber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Distinct Effects of Escitalopram and Vortioxetine on Astroglial L-Glutamate Release Associated with Connexin43
Takashi Shiroyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan
Taro Kishi et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor
Jieon Lee et al.
MOLECULES (2021)
Vortioxetine for generalized anxiety disorder in adults
Nicolas Meza et al.
MEDWAVE (2021)
Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials
Taro Kishi et al.
MOLECULAR PSYCHIATRY (2021)
Efficacy and safety of lurasidone versus placebo as adjunctive to mood stabilizers in bipolar I depression: A meta-analysis
Hui Wang et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Towards selective CNS PET imaging of the 5-HT7 receptor system: Past, present and future
Elina T. L'Estrade et al.
NEUROPHARMACOLOGY (2020)
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia
Stefan Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Pathogenesis and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant α4 subunit of nicotinic ACh receptor
Kouji Fukuyama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Role of the Serotonin Receptor 7 in Brain Plasticity: From Development to Disease
Marianna Crispino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
SLEEP SPINDLES: MECHANISMS AND FUNCTIONS
Laura M. J. Fernandez et al.
PHYSIOLOGICAL REVIEWS (2020)
Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis
Anees Bahji et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Pathomechanism of nocturnal paroxysmal dystonia in autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant α4 subunit of nicotinic ACh receptor
Kouji Fukuyama et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Interaction between Mesocortical and Mesothalamic Catecholaminergic Transmissions Associated with NMDA Receptor in the Locus Coeruleus
Motohiro Okada et al.
BIOMOLECULES (2020)
Upregulated and Hyperactivated Thalamic Connexin 43 Plays Important Roles in Pathomechanisms of Cognitive Impairment and Seizure of Autosomal Dominant Sleep-Related Hypermotor Epilepsy with S284L-Mutant α4 Subunit of Nicotinic ACh Receptor
Kouji Fukuyama et al.
PHARMACEUTICALS (2020)
A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Double-blind,placebo-controlledstudy of lurasidone monotherapy for the treatment of bipolar I depression
Tadafumi Kato et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2020)
Upregulated Connexin 43 Induced by Loss-of-Functional S284L-Mutant α4 Subunit of Nicotinic ACh Receptor Contributes to Pathomechanisms of Autosomal Dominant Sleep-Related Hypermotor Epilepsy
Kouji Fukuyama et al.
PHARMACEUTICALS (2020)
Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials
Wenqiang Kong et al.
FRONTIERS IN PHARMACOLOGY (2020)
Evaluation of electrochemical methods for tonic dopamine detection in vivo
Aaron E. Rusheen et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2020)
Candidate Strategies for Development of a Rapid-Acting Antidepressant Class That Does Not Result in Neuropsychiatric Adverse Effects: Prevention of Ketamine-Induced Neuropsychiatric Adverse Reactions
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Consensus guidelines on managing Rett syndrome across the lifespan
Cary Fu et al.
BMJ PAEDIATRICS OPEN (2020)
Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia
Herbert Y. Meltzer et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2020)
Pharmacology and Therapeutic Potential of the 5-HT7 Receptor
Kevin M. Blattner et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study
Pratap Chokka et al.
CNS SPECTRUMS (2019)
Effects of acute and sub-chronic administrations of guanfacine on catecholaminergic transmissions in the orbitofrontal cortex
Motohiro Okada et al.
NEUROPHARMACOLOGY (2019)
Lurasidone inhibits NMDA receptor antagonist-induced functional abnormality of thalamocortical glutamatergic transmission via 5-HT7 receptor blockade
Motohiro Okada et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study
Eduard Vieta et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Amantadine Combines Astroglial System Xc- Activation with Glutamate/NMDA Receptor Inhibition
Tomosuke Nakano et al.
BIOMOLECULES (2019)
Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor
Kouji Fukuyama et al.
BIOMOLECULES (2019)
Vortioxetine treatment for generalised anxiety disorder: a meta-analysis of anxiety, quality of life and safety outcomes
Bin Qin et al.
BMJ OPEN (2019)
Pharmacological Discrimination of Effects of MK801 on Thalamocortical, Mesothalamic, and Mesocortical Transmissions
Motohiro Okada et al.
BIOMOLECULES (2019)
Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT1A Receptor with 5-HT3 Receptor Inhibition in Rats
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc-
Motohiro Okada et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
Lurasidone Sub-Chronically Activates Serotonergic Transmission via Desensitization of 5-HT1A and 5-HT7 Receptors in Dorsal Raphe Nucleus
Motohiro Okada et al.
PHARMACEUTICALS (2019)
A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder
Bernhard T. Baune et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis
Michael Ostacher et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2018)
Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma
Ilhan Elmaci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis
Marc Krause et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Vortioxetine Treatment for Anxiety Disorder: A Meta-Analysis Study
Anne Yee et al.
CURRENT DRUG TARGETS (2018)
Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission
Kouji Fukuyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Activation of Serotonin 5-HT7 Receptors Modulates Hippocampal Synaptic Plasticity by Stimulation of Adenylate Cyclases and Rescues Learning and Behavior in a Mouse Model of Fragile X Syndrome
Lara Costa et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder
Roger S. McIntyre et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment
Julien Lalut et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study
Melissa P. DelBello et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2017)
Modulation of the consolidation and reconsolidation of fear memory by three different serotonin receptors in hippocampus
S. D. Schmidt et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2017)
CaMKII Autophosphorylation Is Necessary for Optimal Integration of Ca2+ Signals during LTP Induction, but Not Maintenance
Jui-Yun Chang et al.
NEURON (2017)
How serotonin receptors regulate morphogenic signalling in neurons
Alexander Wirth et al.
PROGRESS IN NEUROBIOLOGY (2017)
Synaptic Remodeling Depends on Signaling between Serotonin Receptors and the Extracellular Matrix
Monika Bijata et al.
CELL REPORTS (2017)
The effects of the 5-HT7 receptor on hippocampal long-term potentiation and apoptosis in a rat model of Alzheimer's disease
Nasrin Hashemi-Firouzi et al.
BRAIN RESEARCH BULLETIN (2017)
Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study
Joyce Tsai et al.
CNS SPECTRUMS (2017)
Neural activity, memory, and dementias: serotonergic markers
Alfredo Meneses
BEHAVIOURAL PHARMACOLOGY (2017)
Deletion of the serotonin receptor type 7 disrupts the acquisition of allocentric but not egocentric navigation strategies in mice
Gregory Beaudet et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin
Sarwat Fatima et al.
MOLECULAR ONCOLOGY (2016)
Age-related changes in AMPK activation: Role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways
Antero Salminen et al.
AGEING RESEARCH REVIEWS (2016)
Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study
Trisha Suppes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Serotonin7 receptors in the lateral habenular nucleus regulate depressive-like behaviors in the hemiparkinsonian rats
Ling Na Han et al.
BRAIN RESEARCH (2016)
Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivo
Filippo Andreetta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer's Disease
Felix-Martin Werner et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Which Cognitive Domains are Improved by Treatment with Vortioxetine?
John E. Harrison et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms
David S. Baldwin et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies
Martha Sajatovic et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling
Jaya Gautam et al.
MOLECULAR CANCER (2016)
Effects of 5-HT-7 receptor ligands on memory and cognition
Nicholas Zareifopoulos et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2016)
The 5-HT7 receptor triggers cerebellar long-term synaptic depression via PKC-MAPK
Pellegrino Lippiello et al.
NEUROPHARMACOLOGY (2016)
Multimodality Review of Amyloid-related Diseases of the Central Nervous System
Michelle M. Miller-Thomas et al.
RADIOGRAPHICS (2016)
The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis
Jie Fu et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
Lurasidone for the Treatment of Irritability Associated with Autistic Disorder
Antony Loebel et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2016)
Effects of the selective 5-HT7 receptor antagonist SB-269970 on premature responding in the five-choice serial reaction time test in rats
Agnieszka Nikiforuk et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors
K. W. Andressen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Spinal 5-HT7 receptors induce phrenic motor facilitation via EPAC-mTORC1 signaling
D. P. Fields et al.
JOURNAL OF NEUROPHYSIOLOGY (2015)
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
Atul R. Mahableshwarkar et al.
NEUROPSYCHOPHARMACOLOGY (2015)
ACTIVATION AND BLOCKADE OF SEROTONIN7 RECEPTORS IN THE PRELIMBIC CORTEX REGULATE DEPRESSIVE-LIKE BEHAVIORS IN A 6-HYDROXYDOPAMINE-INDUCED PARKINSON'S DISEASE RAT MODEL
Q. J. Zhang et al.
NEUROSCIENCE (2015)
Stimulation of 5-HT7 Receptor During Adolescence Determines its Persistent Upregulation in Adult Rat Forebrain Areas
Paola Nativio et al.
SYNAPSE (2015)
Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics
Luisa Speranza et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Epac activation initiates associative odor preference memories in the rat pup
Matthew T. Grimes et al.
LEARNING & MEMORY (2015)
Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Antony Loebel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Antony Loebel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Population Pharmacokinetic Meta-Analysis of Vortioxetine in Healthy Individuals
Johan Areberg et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Effect of 5-HT7 receptor blockade on liver regeneration after 60-70% partial hepatectomy
Konstantinos N. Tzirogiannis et al.
BMC GASTROENTEROLOGY (2014)
Neuronal Plasticity: Beyond the Critical Period
Mark Huebener et al.
CELL (2014)
Metformin: From Mechanisms of Action to Therapies
Marc Foretz et al.
CELL METABOLISM (2014)
A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
Roger S. McIntyre et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome
Bianca De Filippis et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Fragile X Syndrome: From molecular pathology to therapy
Thomas Maurin et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways
Jiamei Lian et al.
PSYCHONEUROENDOCRINOLOGY (2014)
The serotonin receptor 7 and the structural plasticity of brain circuits
Floriana Volpicelli et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
Kenji Maeda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
A Head-to-Head Comparison of Aripiprazole and Risperidone for Safety and Treating Autistic Disorders, a Randomized Double Blind Clinical Trial
Ahmad Ghanizadeh et al.
CHILD PSYCHIATRY & HUMAN DEVELOPMENT (2014)
Structural plasticity of dendritic spines: The underlying mechanisms and its dysregulation in brain disorders
Kwok-On Lai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Serotonin and the 5-HT7 receptor: The link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors
Bernhard Svejda et al.
CANCER SCIENCE (2013)
Electrophysiological and pharmacological properties of GABAergic cells in the dorsal raphe nucleus
Yoshihiro Gocho et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2013)
Brain Region-Specific Transcriptomic Markers of Serotonin-1A Receptor Agonist Action Mediating Sexual Rejection and Aggression in Female Marmoset Monkeys
Yves Aubert et al.
JOURNAL OF SEXUAL MEDICINE (2013)
The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways
L. Speranza et al.
NEUROPHARMACOLOGY (2013)
Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats
Agnieszka Nikiforuk et al.
PLOS ONE (2013)
The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers
David Lawrence et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neurons
Maryam S. Vasefi et al.
MOLECULAR BRAIN (2013)
The serotonin 5-HT7 receptors: two decades of research
Evelien Gellynck et al.
EXPERIMENTAL BRAIN RESEARCH (2013)
Effects of the selective 5-HT7 receptor antagonist SB-269970 in animal models of psychosis and cognition
Kerry A. Waters et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Activation of 5-HT7 Serotonin Receptors Reverses Metabotropic Glutamate Receptor-Mediated Synaptic Plasticity in Wild-Type and Fmr1 Knockout Mice, a Model of Fragile X Syndrome
Lara Costa et al.
BIOLOGICAL PSYCHIATRY (2012)
Structural plasticity of dendritic spines
Miguel Bosch et al.
CURRENT OPINION IN NEUROBIOLOGY (2012)
Involvement of 5-HT7 receptors in the pathogenesis of temporal lobe epilepsy
Zhiyong Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
5-HT1A and 5-HT7 receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission
L. Costa et al.
HIPPOCAMPUS (2012)
5-HT7R/G12 Signaling Regulates Neuronal Morphology and Function in an Age-Dependent Manner
Fritz Kobe et al.
JOURNAL OF NEUROSCIENCE (2012)
Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission
Shunsuke Tanahashi et al.
NEUROPHARMACOLOGY (2012)
Levetiracetam inhibits neurotransmitter release associated with CICR
Kouji Fukuyama et al.
NEUROSCIENCE LETTERS (2012)
Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex
Keiko Ohoyama et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
Benny Bang-Andersen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats
M. Horiguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives
Anne Matthys et al.
MOLECULAR NEUROBIOLOGY (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy
Ouissame Mnie-Filali et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
Marc De Hert et al.
WORLD PSYCHIATRY (2011)
An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship
Olga Martins de Brito et al.
EMBO JOURNAL (2010)
Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome
Emily K. Osterweil et al.
JOURNAL OF NEUROSCIENCE (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity
Tadashi Ishibashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex
S. Yamamura et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology
D. Leo et al.
GENES BRAIN AND BEHAVIOR (2009)
Pharmacological Analysis of the Novel, Rapid, and Potent Inactivation of the Human 5-Hydroxytryptamine7 Receptor by Risperidone, 9-OH-Risperidone, and Other Inactivating Antagonists
Jessica A. Knight et al.
MOLECULAR PHARMACOLOGY (2009)
What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
Bradley N. Gaynes et al.
PSYCHIATRIC SERVICES (2009)
Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex
Satoshi Yamamura et al.
PSYCHOPHARMACOLOGY (2009)
Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival
Vaibhav P. Pai et al.
BREAST CANCER RESEARCH (2009)
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report
Maurizio Fava et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like in activity
Ruggero Galici et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Inactivation of the 5-HT7 receptor partially blocks phencyclidine-induced disruption of prepulse inhibition
Svetlana Semenova et al.
BIOLOGICAL PSYCHIATRY (2008)
Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model
Gustavo Liy-Salmeron et al.
HIPPOCAMPUS (2008)
Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice
Mark S. Ansorge et al.
JOURNAL OF NEUROSCIENCE (2008)
Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome
J. L. Neul et al.
NEUROLOGY (2008)
Rapid synaptic scaling induced by changes in postsynaptic firing
Keiji Ibata et al.
NEURON (2008)
Synaptic plasticity: Multiple forms, functions, and mechanisms
Ami Citri et al.
NEUROPSYCHOPHARMACOLOGY (2008)
The Cyclic AMP Cascade Is Altered in the Fragile X Nervous System
Daniel J. Kelley et al.
PLOS ONE (2007)
Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study
Daniel Souery et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Morphogenic signaling in neurons via neurotransmitter receptors and small GTPases
Evgeni Ponimaskin et al.
MOLECULAR NEUROBIOLOGY (2007)
Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents
Pascal Bonaventure et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder
Peter B. Hedlund et al.
NEUROSCIENCE LETTERS (2007)
Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase
Sangwon F. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice
Anna Wesolowska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Carbamazepine prevents breakdown of neurotransmitter release induced by hyperactivation of ryanodine receptor
Shukuko Yoshida et al.
NEUROPHARMACOLOGY (2007)
Constitutive deletion of the serotonin-7 (5-HT7) receptor decreases electrical and chemical seizure thresholds
Jeffrey M. Witkin et al.
EPILEPSY RESEARCH (2007)
Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats
Anna Wesolowska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor
Carol Smith et al.
MOLECULAR PHARMACOLOGY (2006)
Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression
Anna Wesolowska et al.
NEUROPHARMACOLOGY (2006)
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
PB Hedlund et al.
BIOLOGICAL PSYCHIATRY (2005)
5-HT7 receptor is coupled to Gα subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology
E Kvachnina et al.
JOURNAL OF NEUROSCIENCE (2005)
Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task
GS Perez-García et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms
CR Guthrie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents
J Fernández et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression
M Guscott et al.
NEUROPHARMACOLOGY (2005)
Biphasic actions of topiramate on monoamine exocytosis associated with both soluble N-ethylmaleimide-sensitive factor attachment protein receptors and Ca2+-induced Ca2+-releasing systems
M Okada et al.
NEUROSCIENCE (2005)
Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy
M Graf et al.
NEUROSCIENCE LETTERS (2004)
Mice lacking 5-HT7 receptors show specific impairments in contextual learning
AJ Roberts et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task
A Meneses
BEHAVIOURAL BRAIN RESEARCH (2004)
Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors
C Mahé et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine(7) receptor distribution and uncovers 8-hydroxy-2-(di-N-propylamino)tetralin interaction with alpha(2) adrenergic receptors
P Bonaventure et al.
NEUROSCIENCE (2004)
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice
AL Collins et al.
HUMAN MOLECULAR GENETICS (2004)
5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons
K Tokarski et al.
BRAIN RESEARCH (2003)
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
DA Shapiro et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Coupling of neuronal 5-HT7 receptors to activation of extracellular-regulated kinase through a protein kinase A-independent pathway that can utilize Epac
SL Lin et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Altered synaptic plasticity in a mouse model of fragile X mental retardation
KM Huber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus
JLW Yau et al.
NEUROSCIENCE LETTERS (2001)
The cloned human 5-HT7 receptor splice variants:: a comparative characterization of their pharmacology, function and distribution
KA Krobert et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2001)
Subcellular distribution of 5-HT1B and 5-HT7 receptors in the mouse suprachiasmatic nucleus
MA Belenky et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2001)
Depression, sleep physiology, and antidepressant drugs
A Winokur et al.
DEPRESSION AND ANXIETY (2001)
Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist
JJ Hagan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
